3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Ovarian Neoplasms
106
Fallopian Tube Neoplasms
48
Carcinoma, Ovarian Epithelial
31
Uterine Cervical Neoplasms
28
Pancreatic Neoplasms
13
Endometrial Neoplasms
13
Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
10
Recurrence
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Lung Neoplasms
7
Triple Negative Breast Neoplasms
6
Stomach Neoplasms
6
Sarcoma
6
Urinary Bladder Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Peritoneal Neoplasms
5
Cholangiocarcinoma
5
Small Cell Lung Carcinoma
4
Melanoma
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Vulvar Neoplasms
3
Uterine Neoplasms
3
Multiple Myeloma
3
Carcinoma
3
Interventions
Paclitaxel
4
Ifosfamide
4
Filgrastim
4
pegfilgrastim
2
liposomal amphotericin B
2
Therapeutics
2
Ipilimumab
2
Etoposide
2
Cisplatin
2
Carboplatin
2
CTLA-4 Antigen
2
sargramostim
1
ixabepilone
1
aldesleukin
1
Thiotepa
1
Sunitinib
1
Specimen Handling
1
Ribavirin
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Peripheral Blood Stem Cell Transplantation
1
Palivizumab
1
Ondansetron
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Lenograstim
1
Itraconazole
1
Interleukin-12 Subunit p35
1
Interleukin-11
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Seminoma
×
Gemcitabine
×
Gynecologic
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled